ADMA BIOLOGICS, INC. Related Party Transaction, Other Revenues from Transactions with Related Party
ADMA BIOLOGICS, INC. (ADMA) reported Related Party Transaction, Other Revenues from Transactions with Related Party of $35.71 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Income Statement › Other Income
us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty · last filed 2019-05-08
- ADMA BIOLOGICS, INC. related party transaction, other revenues from transactions with related party for the quarter ending 2019-03-31 was $35.71K, a 0.00% change year-over-year.
- ADMA BIOLOGICS, INC. related party transaction, other revenues from transactions with related party for the quarter ending 2018-03-31 was $35.71K.
| Period end | Related Party Transaction, Other Revenues from Transactions with Related Party 3 month |
|---|---|
| 2019-03-31 | $35.71K 10-Q · filed 2019-05-08 |
| 2018-03-31 | $35.71K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |